Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]

Detalles Bibliográficos
Autores principales: Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407945/
https://www.ncbi.nlm.nih.gov/pubmed/37560051
http://dx.doi.org/10.1016/j.jve.2023.100340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407945/
https://www.ncbi.nlm.nih.gov/pubmed/37560051
http://dx.doi.org/10.1016/j.jve.2023.100340

Ejemplares similares